Topical diquafosol for patients with obstructive meibomian gland dysfunction

Br J Ophthalmol. 2013 Jun;97(6):725-9. doi: 10.1136/bjophthalmol-2012-302668. Epub 2013 Apr 12.

Abstract

Aims: To evaluate the effect of topical diquafosol in patients with meibomian gland dysfunction (MGD) using tear film parameters and quantitatively analyse the meibomian gland morphology.

Subjects and methods: The subjects were 19 eyes of 10 patients diagnosed with obstructive MGD. All subjects were given 3% diquafosol ophthalmic solution with instructions to use one drop four times a day. Ocular symptoms were scored from 0 to 14. Lid margin abnormalities were scored from 0 to 4. Changes in the meibomian glands were scored using non-contact meibography (meiboscore). Superficial punctate keratopathy (SPK) was scored from 0 to 3. Meibum was graded from 0 to 3. Tear film production was evaluated by Schirmer's test. Quantitative image analysis of the meibomian glands was performed using the original software.

Results: 10 patients completed more than 4 months of therapy. Ocular symptoms, lid margin abnormalities, SPK score and meibum grade were decreased. Break-up time and tear film meniscus were increased. Mean ratio of the meibomian gland area was significantly increased after treatment (p<0.0001).

Conclusions: Quantitative image analysis was useful for evaluating the morphological changes of the meibomian glands. Topical diquafosol therapy was effective for patients with obstructive MGD.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Eyelid Diseases / drug therapy*
  • Eyelid Diseases / pathology
  • Eyelid Diseases / physiopathology
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Male
  • Meibomian Glands / drug effects*
  • Meibomian Glands / pathology
  • Meibomian Glands / physiology
  • Ophthalmic Solutions / administration & dosage*
  • Polyphosphates / administration & dosage*
  • Tears / physiology
  • Treatment Outcome
  • Uracil Nucleotides / administration & dosage*

Substances

  • Ophthalmic Solutions
  • Polyphosphates
  • Uracil Nucleotides
  • diquafosol